Post-Stroke Sleep Study Found Prolonged Prescribing Without Sleep-Apnea Testing

The dataset describes treatment patterns while leaving important causes of sleep disturbance unresolved.

What the supplied source reports

Of 542 screened acute-stroke inpatients, 290 entered the single-center analysis. Short and prolonged benzodiazepine-or-Z-drug treatment occurred in substantial proportions. None received polysomnographic screening for obstructive sleep apnea, and reported treatment options did not include cognitive behavioral therapy. Several clinical factors were associated with prolonged prescribing.

Limits of the evidence

The study grouped benzodiazepines and Z-drugs under its exposure definition. It was retrospective, had a limited prolonged-treatment sample and did not establish a causal benefit or harm from prescribing. Lack of sleep testing is not proof that every patient had unrecognized apnea.

Implications for forensic interpretation

For reviewing post-stroke sedation, distinguish insomnia symptoms from breathing disorders, pain, communication difficulty and environmental disruption. Obtain the diagnostic rationale rather than inferring it from a hypnotic order. The source supports scrutiny of assessment and treatment choices without diagnosing sleep apnea or medication misuse in an individual patient.

Source and related reading

Source reviewed: Factors Associated with Benzodiazepines Prolonged Term Use in Post Stroke Subjective Sleep Disturban (PMC8200158). Forensic applications above are interpretive analysis of the supplied publication.